Kalbe Farma (Indonesia) provided earnings guidance for the full year 2015. The company expected its full-year 2015 sales to grow 2%-3% year on year and its net profit to fall by 3%-4% year on year, amid slowing macroeconomic conditions.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,490 IDR | -1.97% | -4.49% | -7.45% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.45% | 4.24B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- KLBF Stock
- News PT Kalbe Farma Tbk.
- Kalbe Farma Provides Earnings Guidance for the Full Year 2015